Robot-assisted surgery for advanced lung cancer after combination drug therapy

This trial is studying robotic-assisted surgery for advanced lung cancer patients who have already received a combination of chemotherapy and immunotherapy (PD-1/PD-L1 inhibitor plus platinum-based chemotherapy). Researchers want to see how well this robotic surgical approach works after the medication has helped shrink the tumor. The goal is to evaluate whether using robotic tools during surgery leads to good outcomes for people with stage IIB or III non-small cell lung cancer.

Advanced lung cancer is difficult to treat, and doctors need to know the safest and most effective surgical approaches after using drug treatments. This trial exists to understand whether robotic-assisted surgery combined with this medication approach can help more patients with advanced lung cancer have better outcomes.